Waldman T - Search Results

1

Frequent truncating mutations of STAG2 in bladder cancer.

Solomon DA, Kim JS, Bondaruk J, Shariat SF, Wang ZF, Elkahloun AG, Ozawa T, Gerard J, Zhuang D, Zhang S, Navai N, Siefker-Radtke A, Phillips JJ, Robinson BD, Rubin MA, Volkmer B, Hautmann R, Küfer R, Hogendoorn PC, Netto G, Theodorescu D, James CD, Czerniak B, Miettinen M, Waldman T. Solomon DA, et al. Among authors: waldman t. Nat Genet. 2013 Dec;45(12):1428-30. doi: 10.1038/ng.2800. Epub 2013 Oct 13. Nat Genet. 2013. PMID: 24121789 Free PMC article.

2

Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells.

Kim JS, Crooks H, Dracheva T, Nishanian TG, Singh B, Jen J, Waldman T. Kim JS, et al. Among authors: waldman t. Cancer Res. 2002 May 15;62(10):2744-8. Cancer Res. 2002. PMID: 12019147

3

Proof-of-principle: oncogenic beta-catenin is a valid molecular target for the development of pharmacological inhibitors.

Kim JS, Crooks H, Foxworth A, Waldman T. Kim JS, et al. Among authors: waldman t. Mol Cancer Ther. 2002 Dec;1(14):1355-9. Mol Cancer Ther. 2002. PMID: 12516970

4

B-Raf is dispensable for K-Ras-mediated oncogenesis in human cancer cells.

Kim JS, Lee C, Foxworth A, Waldman T. Kim JS, et al. Among authors: waldman t. Cancer Res. 2004 Mar 15;64(6):1932-7. doi: 10.1158/0008-5472.can-03-3862. Cancer Res. 2004. PMID: 15026326

5

Suppression of tumorigenesis and activation of Wnt signaling by bone morphogenetic protein 4 in human cancer cells.

Nishanian TG, Kim JS, Foxworth A, Waldman T. Nishanian TG, et al. Among authors: waldman t. Cancer Biol Ther. 2004 Jul;3(7):667-75. doi: 10.4161/cbt.3.7.965. Epub 2004 Jul 10. Cancer Biol Ther. 2004. PMID: 15197354 Free article.

6

PTEN gene targeting reveals a radiation-induced size checkpoint in human cancer cells.

Lee C, Kim JS, Waldman T. Lee C, et al. Among authors: waldman t. Cancer Res. 2004 Oct 1;64(19):6906-14. doi: 10.1158/0008-5472.CAN-04-1767. Cancer Res. 2004. PMID: 15466180 Free PMC article.

7

Activation of p53-dependent growth suppression in human cells by mutations in PTEN or PIK3CA.

Kim JS, Lee C, Bonifant CL, Ressom H, Waldman T. Kim JS, et al. Among authors: waldman t. Mol Cell Biol. 2007 Jan;27(2):662-77. doi: 10.1128/MCB.00537-06. Epub 2006 Oct 23. Mol Cell Biol. 2007. PMID: 17060456 Free PMC article.

8

Activated PI3K signaling as an endogenous inducer of p53 in human cancer.

Lee C, Kim JS, Waldman T. Lee C, et al. Among authors: waldman t. Cell Cycle. 2007 Feb 15;6(4):394-6. doi: 10.4161/cc.6.4.3810. Epub 2007 Feb 3. Cell Cycle. 2007. PMID: 17329971 Free PMC article.

9

NHERFs, NEP, MAGUKs, and more: interactions that regulate PTEN.

Bonifant CL, Kim JS, Waldman T. Bonifant CL, et al. Among authors: waldman t. J Cell Biochem. 2007 Nov 1;102(4):878-85. doi: 10.1002/jcb.21518. J Cell Biochem. 2007. PMID: 17786934 Free PMC article. Review.

10

Human somatic cell gene targeting.

Waldman T, Lee C, Nishanian TG, Kim JS. Waldman T, et al. Curr Protoc Mol Biol. 2003 May;Chapter 9:Unit 9.15. doi: 10.1002/0471142727.mb0915s62. Curr Protoc Mol Biol. 2003. PMID: 18265333

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters